Phyllis Whalen

Phyllis Whalen is a seasoned professional in clinical trial management with extensive experience in the pharmaceutical sector. Currently serving as a Senior Clinical Trial Manager at Genmab since May 2021, Phyllis previously held positions at Janssen Pharmaceutical Companies of Johnson & Johnson, Luye Lifesciences USA, and Regeneron Pharmaceuticals, among others. At Celgene, Phyllis worked on cross-therapeutic Phase I-IV trial teams, focusing on hematology/oncology and inflammation and immunology indications, while also acting as the Clinical Trial Manager for a global Phase III Multiple Myeloma trial. Phyllis's career began at Johnson & Johnson and Medarex, with a foundation in clinical operations support and administrative roles. Phyllis earned a Bachelor of Arts in Communications and English from Rutgers University.